Degradation products of extracellular matrix affect cell migration and proliferation.

Biologic scaffolds composed of extracellular matrix (ECM) are utilized in numerous regenerative medicine applications to facilitate the constructive remodeling of tissues and organs. The mechanisms by which the host remodeling response occurs are not fully understood, but recent studies suggest that both constituent growth factors and biologically active degradation products derived from ECM play important roles. The objective of the present study was to determine if degradation of ECM scaffold materials in vitro by methods that are biochemically and physiologically relevant can yield products that possess chemotactic and/or mitogenic activities for fully differentiated mammalian endothelial cells and undifferentiated multipotential progenitor cells. ECM harvested from porcine urinary bladder was degraded enzymatically with pepsin/hydrochloric acid or papain. The ECM degradation products were tested for chemoattractant properties utilizing either 48-well chemotaxis filter migration microchambers or fluorescence-based filter migration assays, and were tested for mitogenic properties in cell proliferation assays. Results showed that ECM degradation products possessed chemotactic and mitogenic activities for multipotential progenitor cells and that the same degradation products inhibited both chemotaxis and proliferation of differentiated endothelial cells. These findings support the concept that degradation products of ECM bioscaffolds are important modulators of the recruitment and proliferation of appropriate cell types during the process of ECM scaffold remodeling.

[1]  J. Hartgerink,et al.  Embryonic-like stem cells from umbilical cord blood and potential for neural modeling. , 2006, Acta neurobiologiae experimentalis.

[2]  P. Roux ENDOSCOPIC URETHROPLASTY WITH UNSEEDED SMALL INTESTINAL SUBMUCOSA COLLAGEN MATRIX GRAFTS: A PILOT STUDY , 2005 .

[3]  J. Fish,et al.  A Comparison of Human and Porcine Acellularized Dermis: Interactions with Human Fibroblasts In Vitro , 2006, Plastic and reconstructive surgery.

[4]  Thomas W. Gilbert,et al.  A quantitative method for evaluating the degradation of biologic scaffold materials , 2007 .

[5]  J. Tibone,et al.  Six-month magnetic resonance imaging follow-up of large and massive rotator cuff repairs reinforced with porcine small intestinal submucosa. , 2004, Journal of shoulder and elbow surgery.

[6]  S. Badylak,et al.  Effect of storage upon material properties of lyophilized porcine extracellular matrix derived from the urinary bladder. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[7]  M. Rudnicki,et al.  Cellular and molecular regulation of muscle regeneration. , 2004, Physiological reviews.

[8]  A. Popel,et al.  Identification of novel short peptides derived from the α4, α5, and α6 fibrils of type IV collagen with anti-angiogenic properties , 2007 .

[9]  T. Jensen,et al.  Regulation of Human Skeletal Stem Cells Differentiation by Dlk1/Pref‐1 , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  George P McCabe,et al.  Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. , 2006, The Journal of bone and joint surgery. American volume.

[11]  Michael Ladisch,et al.  Antimicrobial activity associated with extracellular matrices. , 2002, Tissue engineering.

[12]  D. Zwas,et al.  Heart regeneration in adult MRL mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Duckett,et al.  Is lamina propria matrix responsible for normal bladder compliance? , 1992, The Journal of urology.

[14]  S. Badylak,et al.  Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells. , 2004, Endothelium : journal of endothelial cell research.

[15]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[16]  Artur Lichtenberg,et al.  Preclinical Testing of Tissue-Engineered Heart Valves Re-Endothelialized Under Simulated Physiological Conditions , 2006, Circulation.

[17]  S. Amatschek,et al.  Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment. , 2007, Blood.

[18]  H. Mertsching,et al.  Influence of scaffold thickness and scaffold composition on bioartificial graft survival. , 2003, Biomaterials.

[19]  M. Bissell,et al.  Dynamic reciprocity: how do extracellular matrix and hormones direct gene expression? , 1987, Progress in clinical and biological research.

[20]  F. Rosso,et al.  From Cell–ECM interactions to tissue engineering , 2004, Journal of cellular physiology.

[21]  Donald O Freytes,et al.  Esophageal reconstruction with ECM and muscle tissue in a dog model. , 2005, The Journal of surgical research.

[22]  P. Holtom,et al.  Porcine Small Intestine Submucosa Does Not Show Antimicrobial Properties , 2004, Clinical orthopaedics and related research.

[23]  L A Geddes,et al.  Small intestinal submucosa as a large diameter vascular graft in the dog. , 1989, The Journal of surgical research.

[24]  Stephen F Badylak,et al.  Production and characterization of ECM powder: implications for tissue engineering applications. , 2005, Biomaterials.

[25]  Khamilia Bedelbaeva,et al.  Spallanzani's mouse: a model of restoration and regeneration. , 2004, Current topics in microbiology and immunology.

[26]  S. Badylak,et al.  Marrow-derived cells populate scaffolds composed of xenogeneic extracellular matrix. , 2001, Experimental hematology.

[27]  Ann E Rundell,et al.  Biaxial strength of multilaminated extracellular matrix scaffolds. , 2004, Biomaterials.

[28]  D. McKenna,et al.  Differentiation of umbilical cord blood-derived multilineage progenitor cells into respiratory epithelial cells. , 2006, Cytotherapy.

[29]  J P Hodde,et al.  An investigation of the long-term bioactivity of endogenous growth factor in OASIS Wound Matrix. , 2005, Journal of wound care.

[30]  R C Harruff,et al.  Experimental assessment of small intestinal submucosa as a bladder wall substitute. , 1995, Urology.

[31]  L. Clark,et al.  Expression of preadipocyte factor‐1(Pref‐1), a delta‐like protein, in healing mouse ears , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[32]  Thore Zantop,et al.  Extracellular matrix scaffolds are repopulated by bone marrow‐derived cells in a mouse model of achilles tendon reconstruction , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[33]  Jessica E. Huber,et al.  Extracellular Matrix as a Scaffold for Laryngeal Reconstruction , 2003, The Annals of otology, rhinology, and laryngology.

[34]  M. Sacks,et al.  Quantification of the fiber architecture and biaxial mechanical behavior of porcine intestinal submucosa. , 1999, Journal of biomedical materials research.

[35]  Artur Lichtenberg,et al.  Clinical Application of Tissue Engineered Human Heart Valves Using Autologous Progenitor Cells , 2006, Circulation.

[36]  S. Badylak,et al.  Resorbable bioscaffold for esophageal repair in a dog model. , 2000, Journal of pediatric surgery.

[37]  L. Clark,et al.  A new murine model for mammalian wound repair and regeneration. , 1998, Clinical immunology and immunopathology.

[38]  T. Sakakura,et al.  Expression of Tenascin-C in Stromal Cells of the Murine Uterus During Early Pregnancy: Induction by Interleukin-1α, Prostaglandin E2, and Prostaglandin F2α , 2000 .

[39]  J. Kaufman,et al.  Remodeling of suspended small intestinal submucosa venous valve: an experimental study in sheep to assess the host cells' origin. , 2003, Journal of vascular and interventional radiology : JVIR.

[40]  Jane Sottile,et al.  Regulation of angiogenesis by extracellular matrix. , 2004, Biochimica et biophysica acta.

[41]  M. Harmsen,et al.  The enzymatic degradation of scaffolds and their replacement by vascularized extracellular matrix in the murine myocardium. , 2006, Biomaterials.

[42]  M. Csete,et al.  Oxygen in the Cultivation of Stem Cells , 2005, Annals of the New York Academy of Sciences.

[43]  S. Badylak,et al.  The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. , 1995, Journal of biomedical materials research.

[44]  R. Kream,et al.  A Functionally Coupled μ3-Like Opiate Receptor/Nitric Oxide Regulatory Pathway in Human Multi-Lineage Progenitor Cells1 , 2007, The Journal of Immunology.

[45]  C. McDevitt,et al.  Transforming growth factor-beta1 in a sterilized tissue derived from the pig small intestine submucosa. , 2003, Journal of biomedical materials research. Part A.

[46]  Stephen F Badylak,et al.  Degradation and remodeling of small intestinal submucosa in canine Achilles tendon repair. , 2007, The Journal of bone and joint surgery. American volume.

[47]  S. Badylak,et al.  Identification of extractable growth factors from small intestinal submucosa , 1997, Journal of cellular biochemistry.

[48]  A. Atala,et al.  Acellular collagen matrix as a possible "off the shelf" biomaterial for urethral repair. , 1999, Urology.

[49]  Stephen F Badylak,et al.  Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix. , 2006, Tissue engineering.

[50]  L. Dworkin,et al.  Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. , 2003, Journal of the American Society of Nephrology : JASN.

[51]  Stephen F Badylak,et al.  The basement membrane component of biologic scaffolds derived from extracellular matrix. , 2006, Tissue engineering.